Results 101 to 110 of about 1,272,372 (129)

NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression. [PDF]

Nat Commun
Reddy T, Puri A, Guzman-Rojas L, Thomas C, Qian W, Zhou J, Zhao H, Mahboubi B, Oo A, Cho YJ, Kim B, Thaiparambil J, Rosato R, Martinez KO, Chervo MF, Ayerbe C, Giese N, Wink D, Lockett S, Wong S, Chang J, Krishnamurthy S, Yam C, Moulder S, Piwnica-Worms H, Meric-Bernstam F, Chang J.   +26 more
europepmc   +1 more source

Pomegranate in Cancer Therapy: A Review of Anticancer Potential, Mechanisms and Clinical Challenges in Breast, Colon and Prostate Cancers. [PDF]

Phytother Res
Kitic D, Miladinovic B, Randjelovic M, Szopa A, Seidel V, Sharifi-Rad J, Setzer WN, Calina D.   +7 more
europepmc   +1 more source

A Prospective Tumour Marker for Breast Cancer: YWHAB and Its Role in Promoting Oncogenic Phenotypes. [PDF]

Breast Cancer (Dove Med Press)
Gopaul VL, Winstone L, Gatien BG, Nault BD, Maiti S, Opperman RM, Majumder M.   +6 more
europepmc   +1 more source

Tumor extracellular matrix enhances invasive gene expression of breast cancer cells in 3D patient-derived scaffolds. [PDF]

Sci Rep
Pezeshki PS, Mohammadi Ganjaroudi N, Azimzadeh A, Majidi Zolbin M, Mohammadpour H, Miri SR, Molaei H, Kajbafzadeh AM.   +7 more
europepmc   +1 more source

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4⁺ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype. [PDF]

Cell Mol Life Sci
Arcuschin CD, Kahrizi K, Sayaman RW, DiBenedetto C, Salaberry PJ, Pirker R, Shen Y, Zakraoui O, Schwarzer C, Scapozza A, Caruso JA, Betancur P, Saba JD, Coppé JP, Barcellos-Hoff MH, Kappes D, van 't Veer L, Schor IE, Muñoz DP.   +18 more
europepmc   +1 more source

Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis. [PDF]

Stem Cell Rev Rep
Keoh LQ, Chiu CF, Ramasamy TS.
europepmc   +1 more source

The Role of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Cancer Stem Cell Signaling. [PDF]

Int J Mol Sci
Jung MS, Choi WY, Zhang W, Barrera FN, Perkins RS.   +4 more
europepmc   +1 more source

Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials. [PDF]

Cancer Immunol Immunother
Gao Y, Xu L, Sun R, Gao L, Yan P, Yang X, Wang G, Xian Y, Zhang J, Zhu D.   +9 more
europepmc   +1 more source

OZ-001 Suppresses the Growth of Triple-Negative Breast Cancer and Pancreatic Cancer by Targeting STAT3 Phosphorylation and the Calcium Signaling Pathway. [PDF]

Biomol Ther (Seoul)
Kim J, Kim HK, Lee S, Yu YJ, Ullah A, Kim EY, Yoo H, Chae HJ.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)

Ca-A Cancer Journal for Clinicians, 2002
Mónica Morrow, Barbara Fowble, D D Dershaw   +2 more
exaly